Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5888861 | Bone | 2016 | 8 Pages |
Abstract
Due to the lack of efficacy in preventing fractures, the development of the orally formulated calcitonin was terminated despite the promising results in earlier studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Kim Henriksen, Inger Byrjalsen, Jeppe R. Andersen, Asger R. Bihlet, Luis A. Russo, Peter Alexandersen, Ivo Valter, Per Qvist, Edith Lau, Bente J. Riis, Claus Christiansen, Morten A. Karsdal, SMC021 investigators SMC021 investigators,